F.D.A. Advisers Set to Discuss Merck’s Covid Pill

admin November 30, 2021
If an expert committee votes to recommend it, the drug, molnupiravir, could be authorized within days for patients at high risk of severe illness.

source https://www.nytimes.com/2021/11/30/health/fda-merck-pill-molnupiravir.html

Post a Comment